Exploring a novel target in therapeutic chemistry with CETSA

Jonathan Ellery, Director of Biology at Sitryx, shares his experience of using CETSA^® from Pelago Bioscience, to investigate a new target with established chemistry. CETSA proved useful in addressing concerns about the compound's effectiveness in tissues by confirming the compound's binding and stabilization of the target, while providing insights on target engagement.